Repligen Corporation

Repligen Corporation Q1 2026 Earnings Recap

RGEN Q1 2026 May 6, 2026

Get alerts when RGEN reports next quarter

Set up alerts — free

The stock rose 6.4% following better-than-expected revenue growth, margin expansion, and an improved full-year adjusted EPS outlook supported by strong demand across segments and accelerated strategic initiatives.

Earnings Per Share Beat
$0.48 vs $0.38 est.
+26.3% surprise
Revenue Beat
194255000 vs 192050200 est.
+1.1% surprise

Market Reaction

1-Day +0.53%
5-Day -7.83%

See RGEN alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • Delivered 15% reported revenue growth (11% organic) with $194 million in Q1 sales, driven by broad-based strength across customer segments and geographies.
  • Adjusted operating margin expanded by 160 basis points, aided by disciplined cost management and the strategic sale of the low-margin Polymem business.
  • Maintained full-year organic growth guidance of 9% to 13%, while slightly lowering reported revenue guidance to reflect the Polymem divestiture, which improved margin expectations.
  • Growth led by Analytics (+50%+), Services (+30%+), and double-digit Consumables; strong capital equipment demand supported by easier comps and a healthy order funnel.
  • Advanced strategic priorities with the launch of a transformation office targeting at least one point of annualized margin improvement by end of 2027 and expanded partnerships in China, which delivered the best quarterly revenue in over two years.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit RGEN on AllInvestView.

Get the Full Picture on RGEN

Track Repligen Corporation in your portfolio with real-time analytics, dividend tracking, and more.

View RGEN Analysis